University Diabetes & Endocrine Consultants

The trials here

What the 8 trials at this site are about, from their registry records.

Conditions

• Type 1 diabetes4 trials
• Type 2 diabetes3 trials
• Fatty liver disease (MASLD/MASH)2 trials
• Liver cirrhosis2 trials
• High blood pressure1 trial

Phase

• Phase 23 trials
• Phase 32 trials
• Phase 1/21 trial
• Phase 2/31 trial

Status

• Recruiting3 trials
• Completed2 trials
• Terminated2 trials
• Active, not recruiting1 trial

Lead sponsor

• Biomea Fusion Inc.1 trial
• Boehringer Ingelheim1 trial
• Bristol-Myers Squibb1 trial
• COUR Pharmaceutical Development Company, Inc.1 trial
• Deka Research and Development1 trial
• and 3 more

Running trials

• Recruiting

  A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar

  NCT07754461· Phase 3· Boehringer Ingelheim· Source

  Contact: Boehringer Ingelheim

• Active, not recruiting

  A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes

  NCT07076199· Phase 3· Novo Nordisk A/S· Source

• Recruiting

  CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)

  NCT06783309· Phase 1/2· COUR Pharmaceutical Development Company, Inc.· Source

  Contact: Gina Harris

• Recruiting

  A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes

  NCT05762107· Phase 2· Zucara Therapeutics Inc.· Source

  Contact: Jason Hughes-Palmer

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Type 1 diabetes2 recruiting
• Type 2 diabetes1 recruiting

Closed trials

• Completed

  Innovative Automated Insulin Delivery System for Type 2 Diabetes

  NCT06853990· Deka Research and Development· Source

• Completed

  Phase 2 Trial of BMF-219 in Participants With Type 1 Diabetes Mellitus

  NCT06152042· Phase 2· Biomea Fusion Inc.· Source

• Terminated

  Safety and Effectiveness of BMS-986263 in Adults With Compensated Cirrhosis (Liver Disease) From Nonalcoholic Steatohepatitis (NASH)

  NCT04267393· Phase 2· Bristol-Myers Squibb· Source

• Terminated

  Study Evaluating the Efficacy and Safety of Belapectin for the Prevention of Esophageal Varices in NASH Cirrhosis

  NCT04365868· Phase 2/3· Galectin Therapeutics Inc.· Source